Hughes Melton and Sarah Melton’s marriage and clinic partnership

Hughes Melton and Sarah Melton’s marriage is also a working partnership in addiction treatment and public health. He helped lead Virginia’s opioid response and build access to medication-assisted treatment; she supported their clinic, advocated for patients, and pressed for stronger safeguards against overprescribing. Their shared work presents treatment not as a simple choice between medication and abstinence, but as a difficult balance between access, clinical oversight, and the risks of misuse.

A Clinic Built Around Treatment and Oversight

Hughes Melton established Highpower, a Suboxone clinic in Lebanon, Virginia, in 2000, seeking to treat underserved patients. Sarah Melton, a pharmacy professor and statewide patient advocate, helped run the clinic with him. Their model required urine screening as well as on-site group and individual counseling, joining medication with monitoring and behavioral support rather than treating prescriptions as a stand-alone intervention.

The clinic also became a source of evidence for Sarah Melton’s advocacy. Patients described to her and to the book’s reporter how buprenorphine could be diverted: some prescribers supplied more medication than patients needed, knowing that some might sell it to pay for continued visits; other patients traded it for heroin or pills. The Meltons’ clinic experience therefore put them in a position to discuss not only treatment’s potential benefits but also the ways poor prescribing practice could undermine it.

Shared Work, Different Roles

The two partners took complementary roles in the statewide response. Hughes Melton, described as a younger version of Art Van Zee, was tapped to help direct Virginia’s opioid response. His initiatives included a statewide push for syringe exchange and tighter controls on medication-assisted treatment prescribing. He also worked with Medicaid officials to broaden reimbursement and cover required counseling and care coordination, partly to encourage cash-only clinics to accept insurance, including Medicaid.

Sarah Melton’s work extended beyond the clinic. As a pharmacy professor and naloxone trainer, she had trained more than four thousand doctors about opioid risks and had reported a number of physicians for overprescribing. The account describes the Meltons as so occupied with this work that interviews often took place at night or while they were in their cars. Their partnership thus connected hands-on clinic practice with professional education, oversight, and state policy.

Medication, Risk, and Safeguards

Sarah Melton supported Suboxone as a valuable medicine, while distinguishing it from Subutex, a buprenorphine formulation without naloxone. She reported that the region had seen deaths involving people injecting high doses of Subutex and argued that the problem was worsened when physicians prioritized profit. Because Subutex lacks Suboxone’s added opioid-blocking agent, some patients preferred it; the account also notes that some users valued the ability to take other opioids alongside it. Her position was not a rejection of medication-assisted treatment, but an insistence that the medication and the way it was prescribed mattered.

That stance placed the Meltons between two failures visible in the book: barriers that kept people from treatment and prescribing practices that could encourage diversion or expose patients to harm. Sarah Melton emphasized screening and counseling at Highpower, while Hughes Melton worked to make treatment more available through insurance and state programs. Their approach recognized that widening access and maintaining safeguards were interdependent tasks.

From Local Practice to Statewide Access

The strain on treatment access gave their work broader significance. At the time described, certified physicians were generally limited to treating 100 patients, a federal cap later raised to 275 in response to the crisis. Hughes Melton’s clinic served as a model for expanding medication-assisted treatment in Virginia, while his work with Medicaid officials sought to make clinics’ care and support services reimbursable. Some clinics eventually began accepting insurance, but the book emphasizes that recognition of the need—and the growth of services—reached communities slowly.

The Meltons’ partnership is therefore defined by more than shared clinic management. It joined treatment delivery to public advocacy and policy reform, while keeping the complications of medication-based care in view. Their work insisted on a dual obligation: patients needed timely access to effective treatment, and the systems providing it needed the oversight, counseling, and financial structure that could make that treatment safer and sustainable.